Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: tommysdad who wrote (6068)	5/11/1999 7:30:00 PM
From: Andreas Helke	Read Replies (2) \| Respond to of 6136

From the proxy statement: The exchange ratio is determined by the average closing price of Warner-Lamber stock during the 10 day trading period ending two trading days before the special meeting. In no event will you receive less then 0.8108 or more than 0.93 of a share of Warner-Lambert stock for each share of Agouron stock. Thanks to the recent trading of WLA stock this ratio will be closer to 0.93 then to 0.81 shares. Andreas